Zdrowie i gospodarka · 19/08/2019

FDA Releases Final Guidance on Veterinary Medicinal Products for Aquatic Species

The US Food and Drug Administration (FDA) has made available a final guidance document (GFI #257) developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) to help establish product withdrawal periods for veterinary drugs in aquatic species, based on marker residue depletion studies.